Connors Investor Services Inc Eli Lilly & CO Transaction History

Connors Investor Services Inc

$1.03 Billion
Q3 2024

A detailed history of Connors Investor Services Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Connors Investor Services Inc holds 19,721 shares of LLY stock, worth $15.1 Million. This represents 1.69% of its overall portfolio holdings.

Number of Shares

19,721

Previous 24,168 18.4%

Holding current value

$15.1 Million

Previous $21.9 Million 20.15%

% of portfolio

1.69%

Previous 2.28%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $3.43 Million - $4.27 Million	-4,447 Reduced 18.4%	19,721 $17.5 Million
Q2 2024 Aug 09, 2024	SELL	$724.87 - $909.04 $10,873 - $13,635	-15 Reduced 0.06%	24,168 $21.9 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $49,152 - $65,759	-83 Reduced 0.34%	24,183 $18.8 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $2.4 Million - $2.83 Million	-4,574 Reduced 15.86%	24,266 $14.1 Million
Q3 2023 Nov 22, 2023	SELL	$434.7 - $599.3 $1.2 Million - $1.65 Million	-2,750 Reduced 8.71%	28,840 $15.5 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $2.83 Million - $3.78 Million	-8,059 Reduced 20.33%	31,590 $14.8 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $94,120 - $110,540	303 Added 0.77%	39,649 $13.6 Million
Q4 2022 Feb 15, 2023	SELL	$321.55 - $374.67 $541,811 - $631,318	-1,685 Reduced 4.11%	39,346 $14.4 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $316,937 - $361,183	-1,069 Reduced 2.54%	41,031 $13.3 Million
Q2 2022 Aug 16, 2022	SELL	$278.73 - $327.27 $2.63 Million - $3.09 Million	-9,453 Reduced 18.34%	42,100 $13.7 Million
Q1 2022 May 18, 2022	BUY	$234.69 - $291.66 $1.84 Million - $2.29 Million	7,850 Added 17.96%	51,553 $14.8 Million
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $2.84 Million - $3.52 Million	12,610 Added 40.56%	43,703 $12.1 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $4.79 Million - $5.9 Million	21,627 Added 228.47%	31,093 $7.18 Million
Q2 2021 Aug 10, 2021	BUY	$180.55 - $233.54 $1.09 Million - $1.41 Million	6,055 Added 177.51%	9,466 $2.17 Million
Q1 2021 Sep 15, 2021	SELL	$164.32 - $212.72 $41,080 - $53,180	-250 Reduced 6.83%	3,411 $637,000
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $22,047 - $29,174	-169 Reduced 4.41%	3,661 $618,000
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $14,622 - $16,913	-100 Reduced 2.54%	3,830 $567,000
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $515,667 - $620,600	-3,780 Reduced 49.03%	3,930 $645,000
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $872,041 - $1.08 Million	-7,325 Reduced 48.72%	7,710 $1.07 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $142,738 - $176,794	-1,335 Reduced 8.16%	15,035 $1.98 Million
Q3 2019 Oct 28, 2019	SELL	$106.79 - $116.16 $122,808 - $133,584	-1,150 Reduced 6.56%	16,370 $1.83 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $54,730 - $63,884	-494 Reduced 2.74%	17,520 $1.94 Million
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $544,305 - $640,687	-4,890 Reduced 21.35%	18,014 $2.34 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $4.22 Million - $4.72 Million	-39,825 Reduced 63.49%	22,904 $2.65 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $147,679 - $184,573	1,720 Added 2.82%	62,729 $6.73 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $14,761 - $16,941	-195 Reduced 0.32%	61,009 $5.21 Million
Q1 2018 May 10, 2018	SELL	$74.21 - $87.6 $88,161 - $104,068	-1,188 Reduced 1.9%	61,204 $4.74 Million
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $187,560 - $201,180	2,289 Added 3.81%	62,392 $5.27 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $4.63 Million - $5.14 Million	60,103	60,103 $5.12 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connors Investor Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Connors Investor Services Inc with notifications on news.

Account

Connors Investor Services Inc Eli Lilly & CO Transaction History